Target intelligence / Profile preview

Nuclear prelamin A recognition factor (NARF)

Target
NARF
Molecular classification
Other (nuclear protein, iron-only hydrogenase-like protein)
01

Overview

Nuclear prelamin A recognition factor (NARF) is a nuclear protein that specifically binds to the prenylated C-terminal tail domain of prelamin A, a precursor of lamin A. Its binding depends on the farnesylation status of prelamin A, making it an example of prenyl-dependent protein-protein interaction. NARF partially colocalizes with the nuclear lamina and may be part of a prelamin A endoprotease complex involved in lamin A maturation. Recent studies have uncovered a role for NARF as a transcriptional coactivator in hypoxic breast cancer cells, where it enhances stemness and metastatic features by epigenetically upregulating pluripotency factor genes. Additionally, NARF has been linked to mitochondrial dysfunction and iron metabolism dysregulation in neurological disease contexts such as multiple sclerosis. Structurally, NARF shows limited sequence similarity to iron-only bacterial hydrogenases, and several transcript variants exist due to alternative splicing and RNA editing

Other names
IOP2FLJ10067DKFZp434G0420Iron-only hydrogenase-like protein 2prenyl-dependent prelamin A binding protein
02

Biological functions

Binds prenylated prelamin APotential component of prelamin A endoprotease complexActs as a transcriptional coactivator (in hypoxic cancer cells)Involved in epigenetic regulation via recruitment of demethylasesAssociated with mitochondrial function and iron metabolism
03

Disease associations

Cancer (notably breast cancer stem cell specification and metastasis)Neurodegenerative disease (multiple sclerosis, via iron metabolism dysregulation)Amyotrophic lateral sclerosis (ALS) (genetic association)Childhood astrocytic tumor (genetic association)

Beyond the preview

Go deeper on Nuclear prelamin A recognition factor (NARF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuclear prelamin A recognition factor (NARF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call